Jessica Moehle

	University of Utah Salt Lake City, UT - 84112 (801) 587-4438
My Clinical Research Studies Phase II Study of Imatinib and Pegylated Interferon-a 2B in Imatinib-na?ve GIST Patients Bevacizumab (Avastin ) + Erlotinib as First-line Therapy for Stage IIIB/IV or Recurrent Non-squamous Cell Lung Cancer - Currently Recruiting